Homi Bhabha Cancer Hospital & Research Centre

1 clinical trials · Sponsor

Record	Firm	Date
This is a Multicentre International Study Evaluating CT-based IGABT With / Without Either TRUS During BT/Pre BT MR as Per IBS-GECESTRO-ABS Recommendations for Target contouring-as an Alternative to MRIGABT for Cervical Cancer From Implementation Perspectives Under EMBRACE-III:TRIPLET IMPACT Study. (NCT07249021)	Homi Bhabha Cancer Hospital & Research Centre	2025-11-01

Every clearance here is in the API, with alerts when new ones post.